A Trial Investigating the Pharmacodynamic Properties of NN5401 in Japanese Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Insulin degludec/insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2010 Actual patient number (29) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.